It has been reported that treatment of Familial Mediterranean fever (FMF) patients with colchicine reduced the level of asymmetric dimethlarginine (ADMA), thrombomodulin (TM), and osteoprotegerin (OPG), suggesting an endothelial protective effect of colchicine [65]. This evidence concerns the gene THBD and familial Mediterranean fever.